Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
767.76
+10.22 (1.35%)
Dec 20, 2024, 4:00 PM EST - Market closed
Eli Lilly Stock Forecast
Stock Price Forecast
The 22 analysts with 12-month price forecasts for Eli Lilly stock have an average target of 963.64, with a low estimate of 610 and a high estimate of 1,250. The average target predicts an increase of 25.51% from the current stock price of 767.76.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Eli Lilly stock from 23 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 9 | 11 | 12 | 11 | 11 | 12 |
Buy | 8 | 8 | 8 | 8 | 9 | 9 |
Hold | 3 | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 20 | 21 | 22 | 21 | 22 | 23 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
B of A Securities | B of A Securities | Strong Buy Initiates $997 | Strong Buy | Initiates | $997 | +29.86% | Dec 10, 2024 |
Wolfe Research | Wolfe Research | Buy Initiates $1,000 | Buy | Initiates | $1,000 | +30.25% | Nov 15, 2024 |
Deutsche Bank | Deutsche Bank | Strong Buy Maintains $1,025 → $1,015 | Strong Buy | Maintains | $1,025 → $1,015 | +32.20% | Nov 4, 2024 |
Barclays | Barclays | Buy Maintains $1,025 → $975 | Buy | Maintains | $1,025 → $975 | +26.99% | Oct 31, 2024 |
B of A Securities | B of A Securities | Strong Buy Maintains $1,150 → $1,100 | Strong Buy | Maintains | $1,150 → $1,100 | +43.27% | Oct 31, 2024 |
Financial Forecast
Revenue This Year
46.05B
from 34.12B
Increased by 34.95%
Revenue Next Year
59.17B
from 46.05B
Increased by 28.48%
EPS This Year
13.32
from 5.80
Increased by 129.65%
EPS Next Year
22.44
from 13.32
Increased by 68.49%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 48.2B | 70.3B | 88.7B | |||
Avg | 46.1B | 59.2B | 71.4B | |||
Low | 43.8B | 51.9B | 60.1B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 41.4% | 52.6% | 49.9% | |||
Avg | 35.0% | 28.5% | 20.7% | |||
Low | 28.3% | 12.8% | 1.5% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 14.18 | 30.51 | 41.58 | |||
Avg | 13.32 | 22.44 | 30.39 | |||
Low | 12.76 | 13.17 | 23.92 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 144.5% | 129.1% | 85.3% | |||
Avg | 129.7% | 68.5% | 35.4% | |||
Low | 120.0% | -1.1% | 6.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.